ConductScience.org, home

Paper32406985

Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.

Allam SR and 6 others. Transpl Infect Dis, 2020. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient. Papers, record 32406985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32406985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.
PubMed
Journal
Transpl Infect Dis
PubMed
Year
2020
PubMed
Publication types
Case Reports, Letter
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.77
iCite
Revised in PubMed
2020-12-18
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Allam SRSridhar Rhttps://orcid.org/0000-0001-6051-9443
2Dao AAnnhttps://orcid.org/0000-0003-3457-1568
3Madhrira MMMachaiah M
4Antiporta PBPhilip B
5Nair RRRanjit R
6Guiteau JJJacfranz J
7Reyad AIAshraf I

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, Monoclonal, HumanizedMajor topic
BetacoronavirusMajor topic
Coronavirus InfectionsMajor topic
Pneumonia, ViralMajor topic
Receptors, Interleukin-6Major topic
Aged
Biomarkers
COVID-19
Female
Humans
Inflammation
Kidney Transplantation
Pandemics
SARS-CoV-2
Transplant Recipients

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
35483235Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials.Int Immunopharmacol2022https://conductscience.org/library/papers/35483235PubMed
35400860Coronavirus-19 infection in kidney transplant recipients: A comprehensive review.Indian J Urol2022https://conductscience.org/library/papers/35400860PubMed
34987916Early Fall in C-Reactive Protein (CRP) Level Predicts Response to Tocilizumab in Rapidly Progressing COVID-19: Experience in a Single-Arm Pakistani Center.Cureus2021https://conductscience.org/library/papers/34987916PubMed
34551880SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020.Transplant Proc2021https://conductscience.org/library/papers/34551880PubMed
33946462The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature.Medicina (Kaunas)2021https://conductscience.org/library/papers/33946462PubMed
33641202Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis.Transpl Infect Dis2021https://conductscience.org/library/papers/33641202PubMed
33387393COVID-19 in SOT versus non-SOT.Am J Transplant2021https://conductscience.org/library/papers/33387393PubMed
33246166COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature.Transplant Rev (Orlando)2021https://conductscience.org/library/papers/33246166PubMed
33240518Management of Canadian Pediatric Patients With Glomerular Diseases During the COVID-19 Pandemic: Recommendations From the Canadian Association of Pediatric Nephrologists COVID-19 Rapid Response Team.Can J Kidney Health Dis2020https://conductscience.org/library/papers/33240518PubMed
33240516Management of Pediatric Kidney Transplant Patients During the COVID-19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group.Can J Kidney Health Dis2020https://conductscience.org/library/papers/33240516PubMed
33110739Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients.Curr Transplant Rep2020https://conductscience.org/library/papers/33110739PubMed
32947798A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients' Lives and Allografts.J Clin Med2020https://conductscience.org/library/papers/32947798PubMed
32884871COVID-19 and Hyperinflammatory Syndrome in Children: Kawasaki Disease with Macrophage Activation Syndrome in Disguise?Cureus2020https://conductscience.org/library/papers/32884871PubMed
32650019Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.Kidney Int2020https://conductscience.org/library/papers/32650019PubMed
32568186The compelling arguments for the need of microvascular investigation in COVID-19 critical patients.Clin Hemorheol Microcirc2020https://conductscience.org/library/papers/32568186PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32406985

GET https://conductscience.org/api/papers/v1/32406985/authors